SEC Form 4 · accession 0000849146-18-000031
Lifevantage Corp · LFVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin Rose
Officer — Chief Sales Officer
Period of report
Feb 2, 2018
Accepted (ET)
Feb 6, 2018 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849146
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.44 | Feb 2, 2018 | A | 39,500 | A | — | Feb 1, 2028 | Common Stock | 39,500 | 39,500 | D |
| Phantom SharesF2,F3 | — | Feb 2, 2018 | A | 19,750 | A | — | — | Common Stock | 19,750 | 19,750 | D |
Explanation of responses
- F1This stock option will vest as follows: (i) 1/3 of the option vests on January 1, 2019 and (ii) an additional 1/12 of the option vests each quarter for each of the 24 months following January 1, 2019, subject to continued service with the company.
- F2Each Phantom Share represents the right to be paid in cash an amount equal to any increase in value of a single share of LFVN common stock, measured from December 31, 2017 to December 31, 2018.
- F3Phantom Shares will be settled following certification of achievement of the price-based condition, which will occur no later than March 15, 2019.